Navigation Links
Data Presented at AACR Meeting Shows Peregrine's Selective,Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical,Cancer Models

e quarterly report on Form 10-Q for the quarter ended January 31, 2007. The Company cautions investors not to place undue reliance on the forward-looking statements contained in this press release. Peregrine Pharmaceuticals, Inc. disclaims any obligation, and does not undertake to update or revise any forward-looking statements in this press release


    Contacts:

    GendeLLindheim BioCom Partners

    Investors                                      Media

                              Barbara Lindheim

    (800) 987-8256                                 (212) 918-4650
info@peregrineinc.com

CONTACT: Media, Barbara Lindheim, +1-212-918-4650, or Investors,GendeLLindheim BioCom Partners, +1-800-987-8256, ,both for Peregrine Pharmaceuticals, Inc. info@peregrineinc.com

Web site: http://www.peregrineinc.com/

Ticker Symbol: (NASDAQ-NMS:PPHM)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
4. Clinical Data From Nymox BPH Drug To Be Presented at American Urological Association Meeting
5. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
6. ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data Presented at International Myeloma Workshop
7. Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S. Urology Meetings
8. MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating MacroVascular Outcomes Presented at the American Diabetes Association 67th Scientific Sessions
9. Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S. Urology Meetings
10. ConjuChem Biotechnologies Reports PC-DAC:Exendin-4 Albumin Conjugate Data Presented at American Diabetes Association Annual Meeting
11. New Data Presented on Micardis (Telmisartan) Tablets in Hypertensive Patients With Type 2 Diabetes
Post Your Comments:
(Date:9/5/2008)...W.Va., Sept. 5 /PRNewswire-USNewswire/ -- Cancer p... fog known as chemobrain. Now in,animal studies at...ered,that injections of N-acetyl cysteine (NAC), a...east cancer chemotherapy drugs sometimes induce., ...eptember issue of the,journal Metabolic Brain Dise...
(Date:9/5/2008)...ANCISCO, Calif., Sept. 5 /-... small molecule LFA-1 inhibitors,to treat inflamma...Nasdaq:,SNSS) today announced SARcode,s initiation...FA-1 product candidate for T-cell mediated ophthal...icense agreement providing,SARcode with an exclusi...
(Date:9/5/2008)...nstrates microRNAs Extracted From a Simple Blood D...cal Biomarkers for a Wide Range of ...echnology, Rosetta Genomics is Currently Developin... Cancer, REHOVOT, Israel and JERSEY CITY, New Jer... Genomics, Ltd. (NASDQ: ROSG), a leader in,the dev...
(Date:9/4/2008)...ed orphan designation for the treatment of Acute M...RINCETON, N.J., Sept. 4 /- Celator Ph... Drug Administration (FDA) has granted orphan,drug...Liposome Injection,for the treatment of Acute Myel...ng to conduct two randomized Phase 2,studies with ...
Breaking Medicine Technology:Study Suggests a Possible Way to Offset Chemobrain Memory Loss 2SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 2SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 3Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 2Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 3Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 4Celator Pharmaceuticals Receives Orphan Drug Designation for Anticancer Agent CPX-351 2Virtual game helps children escape realities of burn unit 3211 1Virtual game helps children escape realities of burn unit 3211 2Revisions to College Cost Reduction and Access Act will create barriers to primary care 3209 1Revisions to College Cost Reduction and Access Act will create barriers to primary care 3209 2Seven Finalists Announced for 2007 Insight Award for Customer Advocacy in Healthcare 3208 1Nursesavvy com Promoting Quality Healthcare for Everyone 3206 1Nursesavvy com Promoting Quality Healthcare for Everyone 3206 2
...uest Therapeutics,Inc., a specialty pharmaceutica...ammatory and infectious diseases, today announced,... of Vascana,– a topical formulation designed... its primary end point and demonstrated statistica...reat patient,population. Typically, a probability...
...rogress and upcoming,milestones on its insulin pro...ll/ - SemBioSys,Genetics Inc. , a biotechnology co...ns for metabolic and cardiovascular disease,today...e,development of plant-derived recombinant human i...67th Scientific Sessions of the,American Diabetes ...
Other Medicine Technology:MediQuest Concludes Confirmatory Phase III Study of Raynaud’s,Therapy 2SemBioSys Presents Positive Insulin Data at the American Diabetes,Association Conference 2SemBioSys Presents Positive Insulin Data at the American Diabetes,Association Conference 3SemBioSys Presents Positive Insulin Data at the American Diabetes,Association Conference 4
(Date:9/5/2008)...., Sept. 5 /PRNewswire-USNewswire/ -- The Health R...announced $39 million in grants to,increase and im...ers., "These grants continue President Bush,s his...e services now reach more economically,vulnerable ...fore," HRSA,Administrator Elizabeth M. Duke said. ...
(Date:9/5/2008)...l on John McCain to commit to develop a National A...UL, Minn., Sep. 5 /PRNewswire-USNewswire/ -- The,R... with no mention of the,domestic AIDS epidemic in ...e epidemic overseas. Neither Presidential nominee .... Sarah Palin mentioned AIDS in their remarks,to C...
(Date:9/5/2008)... N.Y., Sept. 5 /PRNewswire/ -- Tonight is a moment...s, entertainment industry,executives, celebrities ...nt advocacy join forces to Stand Up to Cancer. Thi...om 8:00 p.m. to 9:00 p.m. ET on the three,networks...atform to elevate,the discussion about cancer and ...
(Date:9/5/2008)...ept. 5 /PRNewswire-USNewswire/ -- As the general e...onal Federation of Independent,Business ( http://w...andidates for a greater focus on the healthcare co...and Republican conventions are over, NFIB,is askin...t obstacles faced,by small businesses as they furt...
Breaking Medicine News(10 mins):Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 3Health News:The Leukemia & Lymphoma Society: Standing Up to Cancer for 60 Years 2Health News:Conventions Conclude, Fall Campaign Begins: NFIB Looks for More Focus on Small Business Healthcare Concerns 2Health News:Conventions Conclude, Fall Campaign Begins: NFIB Looks for More Focus on Small Business Healthcare Concerns 3
...ge that victims of the terrible 'Elephant Man' cli... a 'reckless' rate.// The drug, a monoclonal anti...mia, multiple sclerosis and rheumatoid arthritis. ...t the victims had been injected 15 times faster th...
...lf of all children in the most rural counties of t...eas, according to a new study //by HHS Agency for ...published in the September-October 2006 issue of A... was led by AHRQ’s Frances Chevarley, Ph.D., analy...
...s can be treated with a low-priced antibiotic, acc...the limbs or scrotum. // A team of scientists at t...t doxycycline gave some relief to patients in the ...e. In addition, the antibiotic killed the causativ...
...earch has revealed that it is tougher to quit ment...be the reason for the excessive smoking-related di...lished in the Archives of Internal Medicine.Nearly...thol cigarettes like Kool or Newport in comparison...
Other Medicine News:Health News:Catastrophic Elephant Man Drug Trial Victims Injected Recklessly 2Health News:Local Health Care Limited for Rural Children 2Health News:Menthol cigarettes harder to quit than regular cigarettes 2
Vision Testing for Infants and Non-Verbal Patients,Using Preferential Looking.
Adult: Letter Acuity, Astigmatic Clock, Binocular Balance, Supression, Fixation Disparity, Stereopsis
Multi-Acuity: Letter Acuity, Tumbling E,and Allen Tests.
Coat-A-Count PSA IRMA is an,immunoradiometric assay intended for the,quantitative measurement of,prostate-specific antigen (PSA) in serum,to aid in the management of prostate,cancer patient
Medicine Products: